Hindustan Bio Sciences Limited (BOM:532041)
India flag India · Delayed Price · Currency is INR
8.49
-0.44 (-4.93%)
At close: Feb 13, 2026

Hindustan Bio Sciences Income Statement

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
Operating Revenue
10.968.1310.539.224.3110.32
Other Revenue
0.4-----
11.358.1310.539.224.3110.32
Revenue Growth (YoY)
40.06%-22.75%14.15%114.19%-58.27%-46.90%
Cost of Revenue
6.894.976.445.792.486.92
Gross Profit
4.463.164.093.441.823.4
Selling, General & Admin
1.791.321.652.622.532.58
Other Operating Expenses
1.060.841.81.14.3110.14
Operating Expenses
2.992.173.523.776.8712.8
Operating Income
1.4710.57-0.34-5.05-9.4
Interest Expense
-0-----
Currency Exchange Gain (Loss)
-----0.05-0.09
Other Non Operating Income (Expenses)
-0.02-0.02-0.04-0.04-0.05-0.07
EBT Excluding Unusual Items
1.450.980.53-0.38-5.14-9.55
Pretax Income
1.450.980.53-0.38-5.14-9.55
Income Tax Expense
-0.03-0.03-0.040.030.03-0.15
Net Income
1.481.010.58-0.4-5.18-9.4
Net Income to Common
1.481.010.58-0.4-5.18-9.4
Net Income Growth
326.30%74.83%----
Shares Outstanding (Basic)
101010101010
Shares Outstanding (Diluted)
101010101010
Shares Change (YoY)
-10.45%-----
EPS (Basic)
0.160.100.06-0.04-0.50-0.92
EPS (Diluted)
0.160.100.06-0.04-0.50-0.92
EPS Growth
376.06%74.83%----
Free Cash Flow
-0.27-14.09-0.5-3.467.53
Free Cash Flow Per Share
-0.03-1.38-0.05-0.340.73
Gross Margin
39.31%38.89%38.84%37.26%42.33%32.94%
Operating Margin
12.95%12.25%5.42%-3.67%-117.17%-91.08%
Profit Margin
13.03%12.38%5.47%-4.39%-120.19%-91.08%
Free Cash Flow Margin
-3.33%-133.83%-5.40%-80.41%72.97%
EBITDA
1.4210.64-0.28-5.01-9.32
EBITDA Margin
12.53%12.27%6.07%-3.06%-116.38%-90.30%
D&A For EBITDA
-0.0500.070.060.030.08
EBIT
1.4710.57-0.34-5.05-9.4
EBIT Margin
12.95%12.25%5.42%-3.67%-117.17%-91.08%
Revenue as Reported
11.358.1310.539.224.3110.32
Advertising Expenses
-0.050.070.070.060.05
Source: S&P Global Market Intelligence. Standard template. Financial Sources.